It was reported that in 2016, the patient underwent a coronary procedure, with implantation of an absorb bioresorbable vascular scaffold (bvs) in the mid right coronary artery (rca) and an absorb bvs in the circumflex (cx) artery.Two years post procedure, the patient presented with symptoms and it was noted that the patient had a significant aneurysm in the mid rca and some aneurysmal appearance in the cx.No additional information was provided.
|
(b)(4).The unique device identifier (udi) is unknown because the part and lot numbers were not provided.There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A review of the lot history record could not be conducted because the part and lot numbers were not provided.The reported patient effect of aneurysm as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use is a known adverse event associated with the use of a coronary scaffold in native coronary arteries.A conclusive cause for the reported patient effect and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.
|